Novel Fights 'Patient' Claim Rehearing In Suprep Suit
Generic drug producer Novel Laboratories Inc. urged the Federal Circuit on Thursday to deny Braintree Laboratories Inc.'s bid for an en banc rehearing on the construction of the term "a patient"...To view the full article, register now.
Already a subscriber? Click here to view full article